| Visualizing influenza virus infection in living mice W Pan, Z Dong, F Li, W Meng, L Feng, X Niu, C Li, Q Luo, Z Li, C Sun, ... Nature communications 4 (1), 2369, 2013 | 125 | 2013 |
| Targeting myeloid-derived suppressor cells for cancer immunotherapy Y Liu, G Wei, WA Cheng, Z Dong, H Sun, VY Lee, SC Cha, DL Smith, ... Cancer Immunology, Immunotherapy 67, 1181-1195, 2018 | 112 | 2018 |
| CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies H Qin, Z Dong, X Wang, WA Cheng, F Wen, W Xue, H Sun, M Walter, ... Science translational medicine 11 (511), eaaw9414, 2019 | 76 | 2019 |
| Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment F Li, L Feng, W Pan, Z Dong, C Li, C Sun, L Chen Journal of virology 84 (22), 12075-12081, 2010 | 49 | 2010 |
| B cell lymphoma immunotherapy using TLR9-targeted oligonucleotide STAT3 inhibitors X Zhao, Z Zhang, D Moreira, YL Su, H Won, T Adamus, Z Dong, Y Liang, ... Molecular Therapy 26 (3), 695-707, 2018 | 29 | 2018 |
| Rapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases W Meng, W Pan, AJX Zhang, Z Li, G Wei, L Feng, Z Dong, C Li, X Hu, ... PLoS One 8 (6), e66276, 2013 | 29 | 2013 |
| Novel BAFF-receptor antibody to natively folded recombinant protein eliminates drug-resistant human B-cell malignancies in vivo H Qin, G Wei, I Sakamaki, Z Dong, WA Cheng, DL Smith, F Wen, H Sun, ... Clinical Cancer Research 24 (5), 1114-1123, 2018 | 28 | 2018 |
| CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia X Wang, Z Dong, D Awuah, WC Chang, WA Cheng, V Vyas, SC Cha, ... Leukemia 36 (4), 1015-1024, 2022 | 17 | 2022 |
| Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions Z Dong, WA Cheng, DL Smith, B Huang, T Zhang, WC Chang, X Wang, ... Cancer Immunology, Immunotherapy 69, 2139-2145, 2020 | 16 | 2020 |
| Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34 W Pan, Z Dong, W Meng, W Zhang, T Li, C Li, B Zhang, L Chen Human Vaccines & Immunotherapeutics 8 (2), 252-259, 2012 | 16 | 2012 |
| Targeting tumor-associated myeloid cells for cancer immunotherapy H Qin, G Wei, D Gwak, Z Dong, A Xiong, LW Kwak Oncoimmunology 4 (3), e983961, 2015 | 13 | 2015 |
| Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates W Pan, L Han, Z Dong, X Niu, Z Li, L Bao, C Li, Q Luo, Z Yang, X Li, ... Antiviral research 107, 1-5, 2014 | 12 | 2014 |
| Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice X Hu, W Meng, Z Dong, W Pan, C Sun, L Chen Virus research 155 (1), 156-162, 2011 | 7 | 2011 |
| Immortalized B cells transfected with mRNA of antigen fused to MITD (IBMAM): an effective tool for antigen-specific T-cell expansion and TCR validation Z Wang, T Zhang, A Anderson, V Lee, S Szymura, Z Dong, B Kuang, E Oh, ... Biomedicines 11 (3), 796, 2023 | 6 | 2023 |
| Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies Z Dong, JY Song, E Thieme, A Anderson, E Oh, WA Cheng, BZ Kuang, ... Blood Advances 7 (6), 918-932, 2023 | 4 | 2023 |
| CAR-T cells targeting BAFF-receptor for B-cell malignancies: a potential alternative to CD19 H Qin, Z Dong, F Wen, W Cheng, H Sun, G Wei, DL Smith, SS Neelapu, ... Blood 130, 3180, 2017 | 3 | 2017 |
| Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated Vaccine J Dong, Z Dong, P Feng, Y Gao, J Li, Y Wang, L Han, Z Li, Q Wang, X Niu, ... Vaccines 11 (2), 391, 2023 | 1 | 2023 |
| Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R H Qin, Z Dong, X Wang, W Cheng, DL Smith, JY Song, I Aldoss, ... Blood 134, 3871, 2019 | 1 | 2019 |
| Novel BAFF-receptor antibody to natively folded and glycosylated recombinant protein eliminates drug resistant B cell malignancies in vivo H Qin, G Wei, I Sakamaki, Z Dong, DL Smith, F Wen, H Sun, WA Cheng, ... Blood 128 (22), 468, 2016 | 1 | 2016 |
| Early Intervention and Favorable Biologic Effects of Personalized Neoantigen Vaccines on the Tumor Immune Microenvironment in Smoldering Waldenstrom Macroglobulinemia S Szymura, S Cha, L Wang, T Zhang, Z Dong, A Anderson, E Oh, Z Wang, ... Blood 142, 212, 2023 | | 2023 |
